BREAKING NEWS: new data suggests Pfizer/BioNTech’s COVID-19 vaccine is 95% effectivenews2020-11-18T13:15:30+00:00November 18th, 2020|PharmaTimes|
ViiV’s cabotegravir scores breakthrough designation for HIV preventionnews2020-11-18T09:38:39+00:00November 18th, 2020|PharmaTimes|
University of Oxford links up with Evox Therapeuticsnews2020-11-18T09:38:25+00:00November 18th, 2020|PharmaTimes|
AZ’s Brilinta reduced rate of stroke and death in high-risk subgroupnews2020-11-18T09:38:06+00:00November 18th, 2020|PharmaTimes|
EU signs COVID-19 vaccine deal with CureVacnews2020-11-18T09:37:50+00:00November 18th, 2020|PharmaTimes|
New inquiry launched to assess impact of pandemic on pharmacy servicesnews2020-11-17T10:09:03+00:00November 17th, 2020|PharmaTimes|
Lead Pharma and Roche enter €260m collaboration agreementnews2020-11-17T10:07:45+00:00November 17th, 2020|PharmaTimes|
Gilead and Novo Nordisk’s NASH trial meets primary endpointnews2020-11-17T10:06:39+00:00November 17th, 2020|PharmaTimes|
UK strikes deal for five million doses of Moderna’s COVID-19 vaccinenews2020-11-17T10:04:49+00:00November 17th, 2020|PharmaTimes|
